Allergy Asthma and Clinical Immunology

Scope & Guideline

Empowering global collaboration in immunology.

Introduction

Welcome to the Allergy Asthma and Clinical Immunology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Allergy Asthma and Clinical Immunology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1710-1492
PublisherBMC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2004 to 2024
AbbreviationALLERGY ASTHMA CL IM / Allerg Asthma Clin. Immunol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Allergy Asthma and Clinical Immunology' primarily focuses on advancing the understanding and treatment of allergic diseases, asthma, and related conditions through empirical research and clinical studies.
  1. Clinical Research in Allergy and Immunology:
    The journal publishes clinical studies that investigate the diagnosis, management, and outcomes of allergic diseases and asthma, emphasizing real-world applications and patient outcomes.
  2. Molecular and Cellular Mechanisms:
    Research exploring the underlying molecular and cellular mechanisms of allergic reactions, asthma pathophysiology, and immune responses, including the roles of cytokines, immune cells, and genetic factors.
  3. Innovative Therapeutic Approaches:
    The journal covers studies on new therapeutic interventions, including biologics, immunotherapy, and novel medications, aimed at improving treatment outcomes for patients with allergies and asthma.
  4. Health Economics and Policy:
    Research that assesses the economic aspects of allergy and asthma management, including cost-effectiveness analyses and healthcare policy implications related to treatment accessibility and patient education.
  5. Patient Education and Quality of Life:
    Studies focusing on the impact of education, awareness, and management strategies on the quality of life of patients with allergic conditions and asthma.
Recent years have seen a shift in focus towards several emerging themes within 'Allergy Asthma and Clinical Immunology'. These trends reflect the current challenges and priorities in allergy and asthma research.
  1. Biologics and Targeted Therapies:
    There is a notable increase in studies examining the efficacy and safety of biologic therapies for asthma and allergic diseases, reflecting a growing interest in precision medicine.
  2. Impact of Environmental Factors on Allergies:
    Research exploring the influence of environmental factors, such as pollution and climate change, on the prevalence and severity of allergic diseases and asthma is gaining traction.
  3. Mental Health and Allergy Comorbidities:
    An increasing number of studies are investigating the relationship between allergic diseases, asthma, and mental health issues, highlighting the psychosocial impact of these conditions.
  4. Patient-Centered Care and Education:
    There is a rising emphasis on patient education, self-management strategies, and the incorporation of patient perspectives in research, reflecting a trend towards more holistic care approaches.
  5. Genetic and Molecular Insights into Allergies:
    Emerging research is focusing on the genetic predispositions to allergic diseases and asthma, utilizing advanced genomic techniques to uncover underlying mechanisms.

Declining or Waning

As the field of allergy and immunology evolves, certain themes have shown a decline in focus within the journal. The following areas appear to be waning based on recent publications.
  1. Traditional Allergy Testing Methods:
    While previously a dominant area of research, the focus on standard skin prick tests and serum IgE testing has diminished as newer, more advanced diagnostic tools and methodologies are being developed.
  2. Generalized Allergy Management Strategies:
    The journal has seen a decline in papers discussing broad, generalized approaches to allergy management, as there is a shift towards personalized and precision medicine tailored to individual patient needs.
  3. Pharmacological Studies of Established Treatments:
    Research focused on older, well-established medications for allergy and asthma has decreased, reflecting a transition towards exploring new therapies and treatment regimens.

Similar Journals

ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Pioneering Research in Immunology and Allergy for a Healthier Future
Publisher: CODON PUBLICATIONSISSN: 0301-0546Frequency: 6 issues/year

ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.

Alergologia Polska-Polish Journal of Allergology

Empowering the allergic community with open access knowledge.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 2353-3854Frequency: 4 issues/year

Alergologia Polska - Polish Journal of Allergology, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished academic journal dedicated to advancing the field of allergy research and treatment. With the ISSN 2353-3854, this journal serves as an essential resource for professionals, researchers, and students alike, offering a platform for the dissemination of novel findings and comprehensive reviews in allergic diseases. The journal emphasizes open access to ensure widespread availability and engagement within the scientific community. Alergologia Polska aims to enhance the understanding of allergy mechanisms, diagnostics, and management strategies, fostering collaboration and innovation among experts in the field. Set against the vibrant backdrop of Poznań, Poland, this publication not only highlights clinical and experimental research but also promotes interdisciplinary discussions that are pivotal for tackling complex allergic conditions globally.

CLINICAL AND EXPERIMENTAL ALLERGY

Advancing the Frontiers of Allergy Research
Publisher: WILEYISSN: 0954-7894Frequency: 12 issues/year

CLINICAL AND EXPERIMENTAL ALLERGY is a premier peer-reviewed journal dedicated to advancing the scientific understanding of allergy and immunology. Published by Wiley in the United Kingdom, this esteemed journal maintains a significant impact factor, reflecting its high standards and influential research contributions. With an impressive history since its inception in 1971, the journal is poised to continue leading the discourse in the field until at least 2024. It is ranked in the Q2 quartile for both Immunology and Allergy categories, further highlighting its reputable standing within the academic community. The journal's Scopus rankings showcase its academic relevance, securing the 49th and 51st positions in the Medicine and Immunology categories, respectively. Researchers, professionals, and students will find vital insights and contemporary research trends within its pages, making it an essential resource for those invested in understanding and addressing allergic diseases and disorders.

Immunity

Shaping the future of immunology through impactful research.
Publisher: CELL PRESSISSN: 1074-7613Frequency: 12 issues/year

Immunity is a premier journal published by CELL PRESS that has positioned itself at the forefront of immunological research since its inception in 1994. With its ISSN 1074-7613 and E-ISSN 1097-4180, this prestigious journal is recognized for its significant contribution to the fields of Immunology, Allergy, and Infectious Diseases, consistently achieving a Q1 ranking in these categories as per 2023 metrics. The journal is highly esteemed within the academic community, holding impressive Scopus rankings—4th out of 344 in Infectious Diseases and 3rd in both Immunology and Immunology and Allergy—placing it in the 98th percentile. Although not an Open Access journal, it provides critical insights and research developments that empower researchers, healthcare professionals, and students alike. With a commitment to advancing scientific knowledge, Immunity is crucial for those interested in understanding immune responses and their implications for health and disease.

Allergy Asthma & Respiratory Disease

Exploring the frontiers of allergy and asthma research.
Publisher: KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGYISSN: 2288-0402Frequency: 4 issues/year

Allergy Asthma & Respiratory Disease is a pioneering journal dedicated to advancing research and clinical practice in the fields of allergy, asthma, and related respiratory diseases. Published by the esteemed Korean Academy of Asthma Allergy & Clinical Immunology, this journal aims to disseminate high-quality, peer-reviewed articles that contribute to the understanding, diagnosis, and treatment of these prevalent health issues. Although it operates under a subscription model, it maintains a robust reputation for being a pivotal resource in respiratory health, attracting authors and researchers worldwide. The journal emphasizes interdisciplinary approaches and encourages submissions that span from molecular biology to public health perspectives, making it a vital platform for professionals, researchers, and students eager to deepen their knowledge in respiratory medicine. With a commitment to fostering academic discourse in South Korea and beyond, Allergy Asthma & Respiratory Disease is positioned as a significant contributor to the global conversation on respiratory health.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Connecting Researchers and Clinicians in Allergy Science.
Publisher: KARGERISSN: 1018-2438Frequency: 12 issues/year

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, published by KARGER, is a distinguished journal dedicated to advancing the field of immunology and allergy research. With an ISSN of 1018-2438 and an E-ISSN of 1423-0097, this journal has been a vital resource since its inception in 1950, continuing to publish influential articles through 2024. Hailing from Switzerland, it holds an important position within the Q3 category in Immunology and Allergy and Q2 in miscellaneous Medicine, reflecting its growing impact in the scientific community. The Scopus rankings showcase its relevance, with a 52nd percentile in Immunology and Allergy and 45th in Immunology and Microbiology. Although not an open-access journal, it plays a critical role in disseminating significant findings and innovations in the understanding of allergic diseases and immunological responses. The INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY is essential for researchers, clinicians, and students eager to stay at the forefront of allergy and immunology developments.

Alergia Astma Immunologia

Empowering research to transform immunological practices.
Publisher: Asthma and Allergy Patients Support OrganizationISSN: 1427-3101Frequency: 4 issues/year

Alergia Astma Immunologia is a dedicated journal focusing on the interdisciplinary fields of immunology and respiratory medicine, published by the Asthma and Allergy Patients Support Organization in Poland. With a commitment to advancing research and sharing knowledge, this journal serves as a platform for scholars and practitioners to discuss critical issues and recent advances in allergy, asthma, and immunological disorders. Despite being in Category Quartiles Q4 for both Immunology and Allergy and Pulmonary and Respiratory Medicine, its importance is highlighted by its continuous publication since 2000, providing a historical perspective on evolving scientific insights. Researchers and clinicians alike benefit from accessing novel findings and case studies that contribute to improved patient outcomes and innovative therapeutic strategies. While the journal currently offers limited open access, its commitment to providing high-quality, peer-reviewed content ensures its relevance in the academic discourse within these vital areas of health science. The journal aims to foster collaboration, stimulate research interest, and promote evidence-based practices within the professional community.

Frontiers in Allergy

Connecting researchers for breakthroughs in allergy science.
Publisher: FRONTIERS MEDIA SAISSN: Frequency:

Frontiers in Allergy is a pioneering open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the frontiers of research in the fields of Immunology and Infectious Diseases. Launched in 2020 and based in Lausanne, Switzerland, this journal provides a dynamic platform for researchers, professionals, and students to share innovative findings and insights related to allergic disorders and their broader immunological implications. With a respectable Q2 ranking in both Immunology and Allergy and Infectious Diseases categories, as well as being indexed in Scopus, this journal is emerging as a significant resource for the scientific community. The open-access model ensures wide dissemination of valuable knowledge, facilitating collaboration and breakthroughs in treatments and understanding of allergies and related conditions. Frontiers in Allergy invites contributions that drive forward the understanding of immune responses, allergy prevention, and management, solidifying its role as a crucial player in the sustainability and growth of health sciences.

Egyptian Journal of Pediatric Allergy and Immunology

Exploring breakthroughs in allergy and immunology for children.
Publisher: EGYPTIAN SOC PEDIATRIC ALLERGY & IMMUNOLOGYISSN: 1687-1642Frequency: 2 issues/year

Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.

Asia Pacific Allergy

Innovative Research for a Healthier Tomorrow
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2233-8276Frequency: 4 issues/year

Asia Pacific Allergy, published by Lippincott Williams & Wilkins, is a prominent academic journal dedicated to advancing research and clinical practice in the fields of dermatology, immunology, and allergy. With its ISSN 2233-8276 and E-ISSN 2233-8268, the journal provides a platform for innovative studies and reviews that cater to an international audience of researchers, healthcare professionals, and students involved in allergy and related disorders. Although it does not currently offer open access to its publications, the journal's robust output from 2015 to 2017 and its ongoing contribution to the literature from 2021 to 2024 showcase the evolving landscape of allergy research in the Asia Pacific region. Recognized in the 2023 Journal Citation Reports, it holds a Q2 ranking in Dermatology and a Q3 ranking in Immunology and Allergy, while its Scopus ranks further emphasize its significance within these domains, positioning it among the top journals in the field. As a source of cutting-edge research, Asia Pacific Allergy plays a vital role in fostering collaboration and knowledge dissemination, ultimately assisting in the betterment of patient care and treatment strategies across the region.